Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Moreno

Showing results (331-340 of 400) with videos related to

Pageof 40
Sort By:
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Scientific Reports|December 8, 2025
High genomic structuring in Euterpe precatoria in the Brazilian Amazônia and new implications for restoration and conservation effortsAna Flávia Francisconi, Matheus Scaketti, Jonathan Andre Morales-Marroquín, et al.
Nature Communications|December 8, 2017
Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidationPauline Scholler, Damien Nevoltris, Dimitri de Bundel, et al.
Journal of the American Academy of Dermatology|March 10, 2022
Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility studyDavid Moreno-Ramírez, Miguel A Duarte-Ferreras, Teresa Ojeda-Vila, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Vaccines|February 26, 2025
Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023-2024 Season in Andalusia, Spain (NIRSEGRAND)David Moreno-Pérez, Aleksandra Korobova, Francisco de Borja Croche-Santander, et al.
Journal of Clinical Medicine|April 30, 2021
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-upClara Carnicer-Cáceres, Jose Antonio Arranz-Amo, Cristina Cea-Arestin, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccineJuan Carlos Tejedor, José Manuel Merino, Manuel Moro, et al.
Neoplasia (New York, N.Y.)|December 27, 2017
Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]Swetha Tati, John C Fisk, Julia Abdullah, et al.
Pageof 40

Showing results (331-340 of 400) with videos related to

Sort By:
Pageof 40
Frontiers in Oncology|July 22, 2022
Long-Term Responders After Autologous Stem Cell Transplantation in Multiple MyelomaAina Oliver-Caldes, Juan Carlos Soler-Perromat, Ester Lozano, et al.
Scientific Reports|December 8, 2025
High genomic structuring in Euterpe precatoria in the Brazilian Amazônia and new implications for restoration and conservation effortsAna Flávia Francisconi, Matheus Scaketti, Jonathan Andre Morales-Marroquín, et al.
Nature Communications|December 8, 2017
Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidationPauline Scholler, Damien Nevoltris, Dimitri de Bundel, et al.
Journal of the American Academy of Dermatology|March 10, 2022
Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility studyDavid Moreno-Ramírez, Miguel A Duarte-Ferreras, Teresa Ojeda-Vila, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.
Vaccines|February 26, 2025
Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023-2024 Season in Andalusia, Spain (NIRSEGRAND)David Moreno-Pérez, Aleksandra Korobova, Francisco de Borja Croche-Santander, et al.
Journal of Clinical Medicine|April 30, 2021
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-upClara Carnicer-Cáceres, Jose Antonio Arranz-Amo, Cristina Cea-Arestin, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccineJuan Carlos Tejedor, José Manuel Merino, Manuel Moro, et al.
Neoplasia (New York, N.Y.)|December 27, 2017
Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]Swetha Tati, John C Fisk, Julia Abdullah, et al.
Pageof 40